Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.

Kuypers DR, Peeters PC, Sennesael JJ, Kianda MN, Vrijens B, Kristanto P, Dobbels F, Vanrenterghem Y, Kanaan N; ADMIRAD Study Team.

Transplantation. 2013 Jan 27;95(2):333-40. doi: 10.1097/TP.0b013e3182725532.

PMID:
23263559
[PubMed - indexed for MEDLINE]
2.

A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.

Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C.

Transplant Proc. 2012 Jan;44(1):121-3. doi: 10.1016/j.transproceed.2011.11.022.

PMID:
22310594
[PubMed - indexed for MEDLINE]
3.

Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.

Nakamura Y, Hama K, Katayama H, Soga A, Toraishi T, Yokoyama T, Kihara Y, Jojima Y, Konno O, Iwamoto H, Takeuchi H, Hirano T, Shimazu M.

Transplant Proc. 2012 Jan;44(1):124-7. doi: 10.1016/j.transproceed.2011.11.051.

PMID:
22310595
[PubMed - indexed for MEDLINE]
4.

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.

Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA.

Drug Des Devel Ther. 2013 Oct 21;7:1253-8. doi: 10.2147/DDDT.S52820. eCollection 2013.

PMID:
24174870
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation.

Calia R, Lai C, Aceto P, Luciani M, Romagnoli J, Lai S, Gargiulo A, Citterio F.

Transplant Proc. 2011 May;43(4):1020-3. doi: 10.1016/j.transproceed.2011.03.048.

PMID:
21620041
[PubMed - indexed for MEDLINE]
6.

Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen.

Eberlin M, Otto G, Krämer I.

Transplant Proc. 2013 Jul-Aug;45(6):2314-20. doi: 10.1016/j.transproceed.2012.10.037. Epub 2013 May 29.

PMID:
23726723
[PubMed - indexed for MEDLINE]
7.

Treatment satisfaction in renal transplant patients taking tacrolimus once daily.

van Boekel GA, Kerkhofs CH, Hilbrands LB.

Clin Ther. 2013 Nov;35(11):1821-9.e1. doi: 10.1016/j.clinthera.2013.09.014. Epub 2013 Oct 15.

PMID:
24135441
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients.

Guirado L, Cantarell C, Franco A, Huertas EG, Fructuoso AS, Fernández A, Gentil MA, Rodríguez A, Paul J, Torregrossa JV, Rodríguez A, Alonso A, Hernández D, Burgos D, Jiménez C, Jimeno L, Lauzurica R, Mazuecos A, Osuna A, Plumed JS, Ruiz JC, Zárraga S; GREAT Study Group.

Am J Transplant. 2011 Sep;11(9):1965-71. doi: 10.1111/j.1600-6143.2011.03571.x. Epub 2011 Jun 10.

PMID:
21668633
[PubMed - indexed for MEDLINE]
Free Article
9.

Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation.

Iaria G, Sforza D, Angelico R, Toti L, de Luca L, Manuelli M, Bellini I, Manzia TM, Anselmo A, Tisone G.

Transplant Proc. 2011 May;43(4):1028-9. doi: 10.1016/j.transproceed.2011.01.130.

PMID:
21620043
[PubMed - indexed for MEDLINE]
10.

Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trial.

Fischer L, Trunečka P, Gridelli B, Roy A, Vitale A, Valdivieso A, Varo E, Seehofer D, Lynch S, Samuel D, Ericzon BG, Boudjema K, Karpf C, Undre N.

Liver Transpl. 2011 Feb;17(2):167-77. doi: 10.1002/lt.22211.

PMID:
21280190
[PubMed - indexed for MEDLINE]
Free Article
11.

Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stable kidney transplant recipients.

Tsuchiya T, Ishida K, Ito S, Deguchi T.

Transplant Proc. 2012 Jan;44(1):118-20. doi: 10.1016/j.transproceed.2011.11.027.

PMID:
22310593
[PubMed - indexed for MEDLINE]
12.

Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen.

Meçule A, Tinti F, Bachetoni A, Poli L, D'Alessandro M, Alessandri C, Umbro I, Nofroni I, Berloco PB, Mitterhofer AP.

Transplant Proc. 2011 May;43(4):1017-9. doi: 10.1016/j.transproceed.2011.02.047.

PMID:
21620040
[PubMed - indexed for MEDLINE]
13.

Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.

Uchida J, Kuwabara N, Machida Y, Iwai T, Naganuma T, Kumada N, Nakatani T.

Transplant Proc. 2012 Jan;44(1):128-33. doi: 10.1016/j.transproceed.2011.11.005.

PMID:
22310596
[PubMed - indexed for MEDLINE]
14.

Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.

Meçule A, Poli L, Nofroni I, Bachetoni A, Tinti F, Umbro I, Barile M, Berloco PB, Mitterhofer AP.

Transplant Proc. 2010 May;42(4):1317-9. doi: 10.1016/j.transproceed.2010.03.123.

PMID:
20534290
[PubMed - indexed for MEDLINE]
15.

Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients.

Wu SW, Tsai HC, Tsai PY, Hung TW, Chang HR, Lian JD.

Swiss Med Wkly. 2013 Aug 27;143:w13850. doi: 10.4414/smw.2013.13850.

PMID:
23986367
[PubMed - indexed for MEDLINE]
Free Article
16.

Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study.

Dopazo C, Rodriguez R, Llado L, Calatayud D, Castells L, Ramos E, Molina V, García R, Fabregat J, Charco R.

Clin Transplant. 2012 Jan-Feb;26(1):E32-7. doi: 10.1111/j.1399-0012.2011.01521.x. Epub 2011 Sep 30.

PMID:
21958123
[PubMed - indexed for MEDLINE]
17.

Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study.

Krämer BK, Charpentier B, Bäckman L, Silva HT Jr, Mondragon-Ramirez G, Cassuto-Viguier E, Mourad G, Sola R, Rigotti P, Mirete JO; Tacrolimus Prolonged Release Renal Study Group.

Am J Transplant. 2010 Dec;10(12):2632-43. doi: 10.1111/j.1600-6143.2010.03256.x. Epub 2010 Sep 14.

PMID:
20840480
[PubMed - indexed for MEDLINE]
Free Article
18.

Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.

Hougardy JM, Broeders N, Kianda M, Massart A, Madhoun P, Le Moine A, Hoang AD, Mikhalski D, Wissing KM, Abramowicz D.

Transplantation. 2011 Mar 15;91(5):566-9. doi: 10.1097/TP.0b013e3182098ff0.

PMID:
21192316
[PubMed - indexed for MEDLINE]
19.

First clinical experience with the new once-daily formulation of tacrolimus.

First MR.

Ther Drug Monit. 2008 Apr;30(2):159-66. doi: 10.1097/FTD.0b013e318167909a. Review.

PMID:
18367975
[PubMed - indexed for MEDLINE]
20.

Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.

Kolonko A, Chudek J, Wiecek A.

Transplant Proc. 2011 Oct;43(8):2950-3. doi: 10.1016/j.transproceed.2011.07.014.

PMID:
21996198
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk